• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Post-partum concern-focused smoking cessation intervention not effective at reducing relapse

byJames EnglandandAnees Daud
March 24, 2016
in Chronic Disease, Obstetrics, Public Health, Pulmonology
Reading Time: 3 mins read
Lung cancer screening may lower motivation for smoking cessation
Share on FacebookShare on TwitterShare on LinkedIn

1. Amongst women who quit smoking during pregnancy, an intervention consisting of cognitive behavioral therapy techniques to address post partum concerns of mood, stress, and weight did not reduce relapse rates at 52 weeks compared to a control support intervention.

2. Smoking relapse was higher in those with more stress, depressive symptoms, younger age, shorter time of having quit at baseline, black race, and lower education level.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: It is common for women to quit smoking during pregnancy, yet many relapse in the post-partum period. Interventions to support women who quit smoking have been shown to be effective at increasing abstinence rate, but the majority of women relapse long-term. The described randomized study sought to evaluate the effectiveness of a program (STARTS) that incorporated cognitive behavioral therapy (CBT) techniques to address post-partum concerns of mood, stress, and weight in comparison to a control program (SUPPORT) that had similar time spent with a smoking cessation counselor, but did not address the aforementioned post-partum concerns.

The results of the study showed rates of biochemically proven abstinence from smoking measured at 12, 24, and 52 weeks post-partum were similar between the two groups. Women with less perceived stress, fewer depressive symptoms, longer period of cessation at baseline, and lower cigarette use were noted to have higher rates of abstinence. This study was well designed to evaluate strategies for smoking cessation and had rigorous objective testing to confirm smoking abstinence. The use of a control program also strengthened the study. However, high rates of abstinence in both groups, compared to prior literature, may have decreased the power and hindered the detection of differences between the two groups. Also, compliance rates were lower in the intervention group compared to the control group, which may have affected the results.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

Relevant Reading: Smoking Cessation, Maintenance, and Relapse Experiences Among Pregnant and Postpartum Adolescents: A Qualitative Analysis

In-Depth [randomized control trial]: This study recruited women between March 2008 and December 2012 who quit smoking during pregnancy and were motivated to remain abstinent. Women were randomized to take part in either the STARTS program that involved specific CBT methods for addressing common post-partum concerns of mood, stress, and weight, or a control SUPPORT program that involved supportive counseling that was matched for time and provided common smoking cessation strategies. Relapse was confirmed by patient reported smoking for 7 consecutive days, exhaled carbon monoxide >8ppm, or salivary cotinine levels exceeding 15 mg/L.

The rates of smoking abstinence for the overall cohort were 38.0% at 12 weeks, 33.7% at 24 weeks, and 24.0% at 52 weeks, and did not differ between the two groups (p=0.28 at 52 weeks). Compliance to planned intervention was noted in 96.7% of control group sessions but only 83.3% of STARTS program sessions (p=.003). Factors that were associated with relapse were younger age (p=0.02), fewer number of weeks quit at baseline (p<0.001), black race (p=0.01), less education (p=0.01), and history of heavier smoking (p=0.02). Women with more depressive symptoms (p=0.04) and higher stress (p=0.003) were also more likely to relapse.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: smoking
Previous Post

Antenatal steroids for fetal lung maturity [Classics Series]

Next Post

Incidence and severity of dengue in pediatric patients higher in Southeast Asia versus Latin America

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Cardiology

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

March 3, 2026
No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer
Cardiology

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

April 13, 2025
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Higher nicotine consumption observed among youth with attention-deficit hyperactivity disorder

May 19, 2025
Next Post
Incidence and severity of dengue in pediatric patients higher in Southeast Asia versus Latin America

Incidence and severity of dengue in pediatric patients higher in Southeast Asia versus Latin America

Parents with poor sleep quality report sleep problems in kids

Parents with poor sleep quality report sleep problems in kids

Epileptogenic foci may be lateralized using functional brain glutamate imaging

Periodontal disease associated with increased rate of cognitive decline in Alzheimer’s dementia

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.